Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated:  3/18/2018
Clinical Research Facility
mi
from
Rochester, NY
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated: 3/18/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated:  3/18/2018
Clinical Research Facility
mi
from
Williamsville, NY
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated: 3/18/2018
Clinical Research Facility
mi
from
Williamsville, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated:  3/18/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated: 3/18/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated:  3/18/2018
Clinical Research Facility
mi
from
West Jordan, UT
An Efficacy and Safety Study of DFN-02
Status: Enrolling
Updated: 3/18/2018
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Oral ALLOD-2 vs. Its Components & vs. Placebo in the Acute Treatment of Migraine (ANODYNE-1)
Single Center, Phase 2B, Randomized, Double-Blind, Placebo, Individual Components, and 2-Doses, Controlled Pilot Study to Assess the Efficacy and Safety of a Single Dose of ALLOD-2 in the Acute Treatment of Migraine (ANODYNE-1)
Status: Enrolling
Updated:  3/18/2018
Annette C. Toledano MD
mi
from
North Miami, FL
Oral ALLOD-2 vs. Its Components & vs. Placebo in the Acute Treatment of Migraine (ANODYNE-1)
Single Center, Phase 2B, Randomized, Double-Blind, Placebo, Individual Components, and 2-Doses, Controlled Pilot Study to Assess the Efficacy and Safety of a Single Dose of ALLOD-2 in the Acute Treatment of Migraine (ANODYNE-1)
Status: Enrolling
Updated: 3/18/2018
Annette C. Toledano MD
mi
from
North Miami, FL
Click here to add this to my saved trials
Sumatriptan as Treatment for Post-traumatic Headache
Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache
Status: Enrolling
Updated:  3/23/2018
Harborview Medical Center
mi
from
Seattle, WA
Sumatriptan as Treatment for Post-traumatic Headache
Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache
Status: Enrolling
Updated: 3/23/2018
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Sumatriptan as Treatment for Post-traumatic Headache
Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache
Status: Enrolling
Updated:  3/23/2018
University of Washington Medical Center
mi
from
Seattle, WA
Sumatriptan as Treatment for Post-traumatic Headache
Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache
Status: Enrolling
Updated: 3/23/2018
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
Status: Enrolling
Updated:  3/27/2018
Boston Children's Hospital at Waltham
mi
from
Waltham, MA
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
Status: Enrolling
Updated: 3/27/2018
Boston Children's Hospital at Waltham
mi
from
Waltham, MA
Click here to add this to my saved trials
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan
Status: Enrolling
Updated:  3/29/2018
Cleveland Clinic, 9500 Euclid Avenue, C-21
mi
from
Cleveland, OH
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan
Status: Enrolling
Updated: 3/29/2018
Cleveland Clinic, 9500 Euclid Avenue, C-21
mi
from
Cleveland, OH
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1327
mi
from
Gilbert, AZ
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1327
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 043
mi
from
Scottsdale, AZ
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 043
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10802
mi
from
Phoenix, AR
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10802
mi
from
Phoenix, AR
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1326
mi
from
Fullerton, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1326
mi
from
Fullerton, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10147
mi
from
Long Beach, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10147
mi
from
Long Beach, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10665
mi
from
Oceanside, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10665
mi
from
Oceanside, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 69
mi
from
San Francisco, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 69
mi
from
San Francisco, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 4
mi
from
Stanford, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 4
mi
from
Stanford, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10129
mi
from
Walnut Creek, CA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10129
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1344
mi
from
Boulder, CO
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1344
mi
from
Boulder, CO
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13071
mi
from
Stamford, CT
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13071
mi
from
Stamford, CT
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10369
mi
from
DeLand, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10369
mi
from
DeLand, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 11141
mi
from
Hialeah, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 11141
mi
from
Hialeah, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 021
mi
from
Jacksonville, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 021
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10715
mi
from
Maitland, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10715
mi
from
Maitland, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10269
mi
from
Orlando, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10269
mi
from
Orlando, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 140
mi
from
Port Orange, FL
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 140
mi
from
Port Orange, FL
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 096
mi
from
Atlanta, GA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 096
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 01
mi
from
Decatur, GA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 01
mi
from
Decatur, GA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13535
mi
from
Douglasville, GA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13535
mi
from
Douglasville, GA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10380
mi
from
Evansville, IN
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10380
mi
from
Evansville, IN
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1334
mi
from
Lenexa, KA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1334
mi
from
Lenexa, KA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10538
mi
from
Brockton, MA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10538
mi
from
Brockton, MA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site CHACHAR
mi
from
New Bedford, MA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site CHACHAR
mi
from
New Bedford, MA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 51
mi
from
Springfield, MA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 51
mi
from
Springfield, MA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 603
mi
from
Watertown, MA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 603
mi
from
Watertown, MA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 115
mi
from
Worcester, MA
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 115
mi
from
Worcester, MA
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 098
mi
from
Ann Arbor, MI
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 098
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 114
mi
from
Kalamazoo, MI
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 114
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 39
mi
from
Golden Valley, MN
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 39
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13534
mi
from
Kansas City, MO
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13534
mi
from
Kansas City, MO
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10552
mi
from
Saint Louis, MO
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10552
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13536
mi
from
Springfield, MO
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13536
mi
from
Springfield, MO
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 148
mi
from
Reno, NV
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 148
mi
from
Reno, NV
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 1369
mi
from
Bronx, NY
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 1369
mi
from
Bronx, NY
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 13544
mi
from
Greensboro, NC
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 13544
mi
from
Greensboro, NC
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
mi
from
Raleigh, NC
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
mi
from
Winston-Salem, NC
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site 10522
mi
from
Canton, OH
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site 10522
mi
from
Canton, OH
Click here to add this to my saved trials
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  4/2/2018
Teva Investigational Site
mi
from
Cincinnati, OH
Assessment of LBR-101 In Chronic Migraine
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 4/2/2018
Teva Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials